A framework for the assessment of the environmental risk posed by pharmaceuticals originating from hospital effluents

Science of the Total Environment

Volumn 493, Issue , 2014, Pages 54-64

  Al Aukidy, Mustafa ^a   Verlicchi, Paola ^a   Voulvoulis, Nikolaos ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Environmental risk; Framework; Hospital effluent; Management; Pharmaceuticals; Treatment

Indexed keywords

DRUG PRODUCTS; EFFLUENT TREATMENT; EFFLUENTS; HOSPITALS; MANAGEMENT; PATIENT TREATMENT; SEWAGE; SEWAGE PUMPING PLANTS; TOXICITY; WASTEWATER TREATMENT; WATER TREATMENT PLANTS;

ENVIRONMENTAL RISKS; FRAMEWORK; HOSPITAL EFFLUENT; MUNICIPAL WASTEWATER TREATMENT PLANTS; RECEIVING WATER BODIES; SITE-SPECIFIC INFORMATION; TREATMENT; WASTEWATER TREATMENT PLANTS;

ENVIRONMENTAL MANAGEMENT; MANAGEMENT;

ATENOLOL; CHLORTETRACYCLINE; CIPROFLOXACIN; CLARITHROMYCIN; CODEINE; DICLOFENAC; DILTIAZEM; DOXYCYCLINE; DRUG; ERYTHROMYCIN; ESTRADIOL; ESTRIOL; ESTRONE; ETHINYLESTRADIOL; IBUPROFEN; IOPROMIDE; KETOPROFEN; LINCOMYCIN; METOPROLOL; METRONIDAZOLE; NAPROXEN; NORFLOXACIN; OFLOXACIN; PARACETAMOL; PROPRANOLOL; SULFAMETHOXAZOLE; SURFACE WATER; TETRACYCLINE; TRIMETHOPRIM; UNINDEXED DRUG; SEWAGE; WASTE WATER; WATER POLLUTANT;

CONCENTRATION (COMPOSITION); DRUG; EFFLUENT; ENVIRONMENTAL RISK; SEWAGE TREATMENT; TOXICITY; WASTE MANAGEMENT; WASTEWATER; METABOLITE; POLLUTANT REMOVAL; POLLUTANT SOURCE; RISK ASSESSMENT; WASTE TREATMENT;

ANALYTICAL PARAMETERS; ARTICLE; BED DENSITY; CONCENTRATION (PARAMETERS); CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; EFFLUENT; ENVIRONMENTAL HAZARD; ENVIRONMENTAL HEALTH; ENVIRONMENTAL IMPACT; ENVIRONMENTAL PARAMETERS; HOSPITAL BED; HOSPITAL MANAGEMENT; HOSPITAL WASTE; HOSPITAL WASTE WATER; PRIORITY JOURNAL; RISK; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY ANALYSIS; URBAN WASTE WATER; VALIDATION PROCESS; WASTE REMOVAL EFFICIENCY; WASTE WATER; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT; WATER POLLUTION; WORKFLOW; ANALYSIS; CHEMISTRY; ENVIRONMENTAL MONITORING; HOSPITAL; SEWAGE; STATISTICS AND NUMERICAL DATA; WATER POLLUTANT; CHEMICAL ANALYSIS; DILUTION; ENVIRONMENTAL IMPACT ASSESSMENT; POLLUTION TRANSPORT; WASTE COMPONENT REMOVAL;

ENVIRONMENTAL MONITORING; HOSPITALS; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; SEWAGE; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL; WATER POLLUTION, CHEMICAL;

EID: 84902482574     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2014.05.128     Document Type: Article

References (58)

1. Al Aukidy M., Verlicchi P., Jelic A., Petrovic M., Barcelò D. Monitoring release of pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP effluents and their receiving rivers in the Po Valley, Italy. Sci Total Environ 2012, 438:15-25.
2. Ashton D., Hilton M., Thomas K.V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 2004, 333:167-184.
3. Beier S., Cramer C., Köster S., Mauer C., Palmowski L., Schröder H.F.R., et al. Full scale membrane bioreactor treatment of hospital wastewater as forerunner for hot-spot wastewater treatment solutions in high density urban areas. Water Sci Technol 2011, 63:66-71.
4. Besse J.P., Garric J. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation. Toxicol Lett 2008, 176:104-123.
5. Bottoni P., Caroli S., Caracciolo A.B. Pharmaceuticals as priority water contaminants. Toxicol Environ Chem 2010, 92:549-565.
6. Bound J.P., Voulvoulis N. Predicted and measured concentrations for selected pharmaceuticals in the UK rivers: implications for risk assessment. Water Res 2006, 40:2885-2892.
7. Caldwell D.J., Mastrocco F., Anderson P.D., Länge R., Sumpter J.P. Predicted-no-effect concentrations for the steroid estrogens estrone, 17β-estradiol, estriol, and 17α-ethinylestradiol. Environ Toxicol Chem 2012, 31:1396-1406.
8. Chèvre N., Coutu S., Margot J., Wynn H.K., Bader H., Scheidegger R., et al. Substance flow analysis as a tool for mitigating the impact of pharmaceuticals on the aquatic system. Water Res 2013, 47:5-2995.
9. Coutu S., Rossi L., Barry D.A., Rudaz S., Vernaz N. Temporal variability of antibiotics fluxes in wastewater and contribution from hospitals. PLoS ONE 2013, 8:1-8.
10. Czekalski N., Berthold T., Caucci S., Egli A., Bürgmann H. Increased levels of multiresistant bacteria and resistance genes after wastewater treatment and their dissemination into Lake Geneva, Switzerland. Front Microbiol 2012, 3:1-18. [Issue MAR].
11. De Voogt P., Janex-Habibni M.L., Sacher F., Puijker L., Mons M. Development of a common priority list of pharmaceuticals relevant for water cycle. Water Sci Technol 2009, 59:39-46.
12. Deo R.P., Halden R.Y. Pharmaceuticals in the built and natural water environment of the United States. Water 2013, 5:1346-1365.
13. Dolar D., Gros M., Rodriguez-Mozaz S., Moreno J., Comas J., Rodriguez-Roda I., et al. Removal of emerging contaminants from municipal wastewater with an integrated membrane system, MBR-RO. J Hazard Mater 2012, 239-240:64-69.
14. Escher B.I., Baumgartner R., Koller M., Treyer K., Lienert J., McArdell C.S. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res 2011, 45:75-92.
15. European Community Directive 2013/39/EU of the European parliament and of the council of 12 August 2013 amending Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of water policy 2013.
16. Ginebreda A., Jelic A., Petrovic M., de Alda M.L., Barcelo D. New indexes for compound prioritization and complexity quantification on environmental monitoring inventories. Environ Sci Pollut Res 2012, 19(4):958-970.
17. Gros M., Petrović M., Ginebreda A., Barceló D. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ Int 2010, 36:15-26.
18. Halling-Sørensen B. Algal toxicity of antibacterial agents used in intensive farming. Chemosphere 2000, 40:731-739.
19. Heberer T., Feldmann D. Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents-modeling versus measurements. J Hazard Mater 2005, 122:211-218.
20. Hernando M.D., Mezcua M., Fernandez-Alba A.R., Barceló D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006, 69:334-342.
21. Jia R., Jing D., Li H., Xie K., Huang T., Zhang Z., et al. Membrane bioreactor process for removing selected antibiotics from wastewater at different solids retention times. Fresenius Environ Bull 2011, 20:754-763.
22. Jjemba P.K. Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. Ecotoxicol Environ Saf 2006, 63:113-130.
23. Johnson A.C., Williams R.J. A model to estimate influent and effluent concentrations of estradiol, estrone and ethinylestradiol at sewage treatment works. Environ Sci Technol 2004, 38:3649-3658.
24. Kümmerer K., Helmers E. Hospital effluents as a source of gadolinium in the aquatic environment. Environ Sci Technol 2000, 34:573-577.
25. Le Corre K., Ort C., Kateley D., Allen B., Escher B., Keller J. Consumption-based approach for assessing the contribution of hospital towards the load of pharmaceutical residues in municipal wastewater. Environ Int 2012, 45:99-111.
26. Lienert J., Koller M., Konrad J., McArdell C.S., Schuwirth N. Multiple-criteria decision analysis reveals high stakeholder preference to remove pharmaceuticals from hospital wastewater. Environ Sci Technol 2011, 45:3848-3857.
27. Lipp P., Gross H.J., Tiehm A. Improved elimination of organic micropollutants by a process combination of membrane bioreactor (MBR) and powdered activated carbon (PAC). Desalin Water Treat 2012, 42(1-3):65-72.
28. 2. Water Sci Technol 2013, 67:854-862.
29. NRMMC Australian guidelines for water recycling: managing health and environmental risks (phase 2): augmentation of drinking water supplies 2008, The Natural Resource Management Ministerial Council (NRMMC), the Environment and Heritage Council (EPHC) and the National Health and Medical Research Council (NHMRC), Canberra, Australia, [159 pp.].
30. Oaks J.L., Gilbert M., Virani M.Z., Watson R.T., Meteyer C.U., Rideout B.A., et al. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 2004, 427:630-633.
31. Ort C., Lawrence M., Reungoat J., Eagleham G., Carter S., Keller J. Determination of the fraction of pharmaceutical residues in wastewater originating from a hospital. Water Res 2010, 44:605-615.
32. Ortiz de Garcia S., Pinto Pinto G., Garcia Encina P., Mata R.I. Consumption and occurrence of pharmaceutical and personal care products in the aquatic environment in Spain. Sci Total Environ 2013, 444:451-465.
33. Pauwels B., Verstraete W. The treatment of hospital wastewater: an appraisal. J Water Health 2006, 4:405-416.
34. Perazzolo C., Morasch B., Kohn T., Magnet A., Thonney D., Chèvre N. Occurrence and fate of micropollutants in the Vidy Bay of Lake of Geneva, Switzerland. Part I: priority list for environmental risk assessment of pharmaceuticals. Environ Toxicol Chem 2010, 28:1649-1657.
35. Philips P.J., Chalmers A.T., Gray J.L., Kolpin D.W., Foreman W.T., Wall G.R. Combined sewer overflows: an environmental source of hormones and wastewater micropollutants. Environ Sci Technol 2012, 46:5336-5343.
36. PILLS Project Pharmaceutical input and elimination from local sources. Final report of the European Cooperation Project PILLS available at the web site:, [last access May 26th 2014]. http://www.pills-project.eu/.
37. Radjenovic J., Petrovic M., Barcelo D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res 2009, 43:831-841.
38. Reif R., Omil F., Lema M. Removal of pharmaceuticals by membrane bioreactor (MBR) technology. Analysis, removal, effects and risk of pharmaceuticals in the water cycle occurrence and transformation in the environment comprehensive analytical chemistry 2013, 62:287-317. Elsevier. M. Petrovic, S. Perez, D. Barcelo (Eds.).
39. Riazul Haq M., Metcalfe C., Li H., Parker W. Discharge of pharmaceuticals into municipal sewers from hospitals and long-term care facilities. Water Qual Res J Can 2012, 47:140-152.
40. Richardson S.D., Ternes T.A. Water analysis: emerging contaminants and current issues. Anal Chem 2011, 83:4614-4648.
41. Roos V., Gunnarsson L., Fick J., Larsson D.G.J., Rudén C. Prioritising pharmaceuticals for environmental risk assessment: towards adequate and feasible first-tier selection. Sci Total Environ 2012, 421-422:102-110.
42. Routledge E.J., Sheahan D., Desbrow C., Brighty G.C., Waldock M., Sumpter J.P. Identification of estrogenic chemicals in STW effluent. 2. In vivo responses in trout and roach. Environ Sci Technol 1998, 32:1559-1565.
43. Ruel M., Choubert S., Budzinski J., Miège H., Esperanza C., Coquery M. Occurrence and fate of relevant substances in wastewater treatment plants regarding water framework directive and future legislations. Water Sci Technol 2012, 65:1179-1189.
44. Santos L.H., Gros M., Rodriguez-Mozaz S., Delerue-Matos C., Pena A., Barceló D., et al. Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals. Sci Total Environ 2013, 461-462:302-316.
45. Schuster A., Hädrich C., Kümmerer K. Flows of active pharmaceutical ingredients originating from health care practices on a local, regional, and nationwide level in Germany-is hospital effluent treatment an effective approach for risk reduction?. Water Air Soil Pollut Focus 2008, 8:457-471.
46. Sui Q., Wang B., Zhao W.T., Huang J., Yu G., Deng S.B., et al. Identification of priority pharmaceuticals in the water environment of China. Chemosphere 2012, 89:280-286.
47. Thomas K., Dye C., Schlabach M., Langford K.H. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospital and a wastewater treatment works. J Environ Monit 2007, 9:1410-1418.
48. Tong C., Zhuo X., Guo Y. Occurrence and risk assessment of four typical fluoroquinolone antibiotics in raw and treated sewage and in receiving waters in Hangzhou, China. J Agric Food Chem 2011, 59:7303-7309.
49. Van der Aa N.G.F.M., Kommer G.J., van Moonfort J.E., Versteegh J.F.M. Demographic projections of future pharmaceutical consumption in The Netherlands. Water Sci Technol 2011, 63:825-831.
50. Verlicchi P., Galletti A., Masotti L. Management of hospital wastewaters: the case of the effluent of a large hospital situated in a small town. Water Sci Technol 2010, 61:2507-2519.
51. Verlicchi P., Galletti A., Petrović M., Barceló D. Hospital effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options. J Hydrol 2010, 389:416-428.
52. Verlicchi P., Al Aukidy M., Galletti A., Petrovic M., Barceló D. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Sci Total Environ 2012, 430:109-118.
53. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment - a review. Sci Total Environ 2012, 429:123-155.
54. Verlicchi P., Galletti A., Al Aukidy M. Hospital wastewaters: quali-quantitative characterization and strategies for their treatment and disposal, Springer. Water treatment and pollution prevention: advances in research 2013, 225-251. Springer, UK. S.K. Sharma, R. Sanghi (Eds.).
55. Verlicchi P., Galletti A., Petrovic M., Barceló D., Al Aukidy M., Zambello E. Removal of selected pharmaceuticals from domestic wastewater in an activated sludge system followed by a horizontal subsurface flow bed - analysis of their respective contributions. Sci Total Environ 2013, 454-455:411-425.
56. Verlicchi P., Zambello E., Al Aukidy M. Removal of pharmaceuticals by conventional wastewater treatment plants. Analysis, removal, effects and risk of pharmaceuticals in the water cycle occurrence and transformation in the environment comprehensive analytical chemistry 2013, 62:231-286. Elsevier. M. Petrovic, S. Perez, D. Barcelo (Eds.).
57. Verlicchi P., Al Aukidy M., Jelic A., Petrović M., Barceló D. Comparison of measured and predicted concentrations of selected pharmaceuticals in wastewater and surface water: a case study of a catchment area in the Po Valley (Italy). Sci Total Environ 2014, 470-471:844-854.
58. Wijekoon K.C., Hai F.I., Kang J., Price W.E., Guo W., Ngo H.H., et al. The fate of pharmaceuticals, steroid hormones, phytoestrogens, UV-filters and pesticides during MBR treatment. Bioresour Technol 2013, 144:247-254.